Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07389473 · ClinicalTrials.gov registry record
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
A clinical trial of ADHD and Mood Disorders, sponsored by Gaize.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07389473: Recruiting study of ADHD and Mood Disorders, sponsored by Gaize.
NCT07389473 is a study of ADHD and Mood Disorders that is actively recruiting participants, run by Gaize. The registered enrollment target is 50 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07389473, a study of ADHD and Mood Disorders, is actively recruiting participants, sponsored by Gaize.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
Primary Outcome
Accuracy of the Gaize device in detecting eye-movement metrics consistent with prescribed psychotropic medication use, as determined by Drug Recognition Expert (DRE) testing protocols in a controlled virtual environment.
Conditions Studied
Interventions
- DRUG Prescription Psychotropic Medications
Study Locations (1)
Pennsylvania
- Gaize - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-17 |
| Est. Completion | 2028-08 |
What NCT07389473 shows while recruiting
NCT07389473 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (74% lower).
The record links to 5 conditions, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Prescription Psychotropic Medications is the first listed.
NCT07389473 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07389473 about?
NCT07389473 is a clinical study titled "Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device". The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
What is the current status of trial NCT07389473?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-04-17. Estimated completion is 2028-08.
What conditions does trial NCT07389473 study?
This clinical trial studies the following conditions: ADHD, Mood Disorders, Depression Disorders, Bipolar Disorder (BPD), Anxiety Disorder Generalized.
What interventions are being tested in trial NCT07389473?
The interventions under investigation include: Prescription Psychotropic Medications (DRUG).
Who is sponsoring clinical trial NCT07389473?
This trial is sponsored by Gaize, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07389473 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07389473's enrollment target sits among peer trials
50 45th of 75 higher than 28 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI